Effects of Chronic Nicotine Exposure on Mood and Anxiety Disorders in Brain Organoids
Author Information
Author(s): Proud Emma K., RodrÃguez-Ruiz Mar, Gummerson Dana M., Vanin Sebastian, Hardy Daniel B., Rushlow Walter J., Laviolette Steven R.
Primary Institution: University of Western Ontario
Hypothesis
Chronic nicotine exposure during prenatal development alters molecular and transcriptomic markers associated with mood and anxiety disorders.
Conclusion
Chronic nicotine exposure leads to significant alterations in molecular markers and gene expression related to mood and anxiety disorders in human cerebral organoids.
Supporting Evidence
- Nicotine exposure altered molecular markers of neural identity and mood disorders.
- RNA sequencing revealed transcriptomic changes in genes related to neurogenesis.
- Long-term effects included persistent disruptions in excitatory/inhibitory balance.
Takeaway
When babies are exposed to nicotine before they are born, it can change how their brains develop, which might make them more likely to feel sad or anxious later in life.
Methodology
The study used human cerebral organoids exposed to nicotine to analyze molecular and transcriptomic changes through immunofluorescence, qPCR, and RNA sequencing.
Potential Biases
Potential biases may arise from the use of specific cell lines and the controlled laboratory environment.
Limitations
The study primarily used in vitro models, which may not fully replicate in vivo conditions.
Participant Demographics
Three human induced pluripotent stem cell lines from healthy individuals, including two males aged 29 and one female aged 24.
Statistical Information
P-Value
0.0271
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website